Similar Search Results

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

Persson, Ulf; Svensson, Johanna; Pettersson, Billie - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 217-225

Sweden has experienced a national value-based pricing (VBP) system for innovative outpatient drugs operated by the Pharmaceutical Benefits Board — LFN (now called the Dental and Pharmaceutical Benefits agency — TLV) since 2002. VBP has the character of a monopoly system, leading to...

Persistent link: https://www.econbiz.de/10011000768

Authors’ Reply to Godman and Gustafsson: “A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing”

Persson, Ulf; Svensson, Johanna; Pettersson, Billie - In: Applied Health Economics and Health Policy 11 (2013) 1, pp. 83-84

Persistent link: https://www.econbiz.de/10011000861

A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden

Persson, Ulf; Willis, Michael; Ödegaard, Knut - In: The European Journal of Health Economics 11 (2010) 2, pp. 195-203

Persistent link: https://www.econbiz.de/10009404141

Reimbursement and clinical guidance for pharmaceuticals in Sweden

Anell, Anders; Persson, Ulf - In: The European Journal of Health Economics 6 (2005) 3, pp. 274-279

Persistent link: https://www.econbiz.de/10009404270

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

Persson, Ulf; Svensson, Johanna; Pettersson, Billie - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 217-225

Sweden has experienced a national value-based pricing (VBP) system for innovative outpatient drugs operated by the Pharmaceutical Benefits Board - LFN (now called the Dental and Pharmaceutical Benefits agency - TLV) since 2002. VBP has the character of a monopoly system, leading to reimbursement...

Persistent link: https://www.econbiz.de/10010552620

Value of a QALY and VSI estimated with the chained approach

Olofsson, Sara; Gerdtham, Ulf-G.; Hultkrantz, Lars; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 7, pp. 1063-1077

Persistent link: https://www.econbiz.de/10012220983

ARTICLES - Relative risk values of non-fatal traffic injuries - A comparison between contingent valuation, risk-risk trade off and standard gamble methods

Persson, Ulf; Trawén, Anna; Norinder, Anna; Hjalte, Krister - In: Swiss journal of economics and statistics 137 (2001) 1, pp. 117

Persistent link: https://www.econbiz.de/10006513253

Nettohälsoanalys - ett nytt sätt att värdera hälsopolitik och säkerhetsregleringar?

Hjalte, Krister; Persson, Ulf - In: Ekonomisk debatt 26 (1998) 3, pp. 189-199

Persistent link: https://www.econbiz.de/10009916852

Kostnadseffektivitetsanalyser : ett instrument för en långsiktigt hållbar läkemedelsmarknad?

Persson, Ulf; Nordling, Sara; Pettersson, Billie - In: Ekonomisk debatt 37 (2009) 3, pp. 42-53

Persistent link: https://www.econbiz.de/10009917155

The Value of a Statistical Life in Transport: Findings from a New Contingent Valuation Study in Sweden

Persson, Ulf; Norinder, Anna; Hjalte, Krister; Gralén, … - In: Journal of risk and uncertainty : JRU 23 (2001) 2, pp. 121-134

Persistent link: https://www.econbiz.de/10007042498